Prashant Patel
Known title: Chief Strategy OfficerCIK: 0001617460
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
SCNX Shares Drop 19% After Hours Amid Reverse Split. SCNX shares fell 19% in after‑hours trading after the company announced a reverse stock split. The reverse split will consolidate shares, potentially raising the share price but also reducing the number of shares outstanding. The drop comes while the stock sits near its 12‑month low and has a very low RSI, indicating a possible oversold condition. The reverse split may be a move to meet listing requirements and support future trading.
Transaction History
| MEDS | ▼ Sell | Other | 100,000 | $500 | 6/22/2026 | View on chart |
| MEDS | ▲ Buy | Grant | 5,000,000 | $1.0M | 3/31/2026 | View on chart |
| MEDS | ▲ Buy | Grant | 1,882,247 | $0 | 3/21/2025 | View on chart |
| MEDS | ▲ Buy | Grant | 1,500,000 | $0 | 3/21/2025 | View on chart |
| MEDS | ▲ Buy | Grant | 700,000 | $0 | 3/21/2025 | View on chart |
| SCNX | ▲ Buy | Grant | 150,000 | $0 | 1/5/2024 | View on chart |
| SCNX | ▲ Buy | Grant | 8,620 | $0 | 9/1/2022 | View on chart |
| SCNX | ▼ Sell | Open Market | 7,500 | $33K | 4/19/2021 | View on chart |
| SCNX | ▼ Sell | Open Market | 7,500 | $40K | 12/14/2020 | View on chart |
| SCNX | ▼ Sell | Open Market | 7,000 | $38K | 7/14/2020 | View on chart |
| SCNX | ▼ Sell | Open Market | 500 | $3K | 7/13/2020 | View on chart |
| SCNX | ▲ Buy | Grant | 50,000 | $306K | 4/14/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
MEDS hits $1M monthly Corexa revenue, unveils health app
DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.
MEDS hits $1M monthly Corexa revenue, unveils health app. DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.